Skip Nav Destination
First Edition
Research Article July 26 2024
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based immunochemotherapy in relapsed indolent B-cell lymphoma
Pier Luigi Luigi Zinzani,Huaqing Wang,Jifeng Feng,Tae Min Kim,Rong Tao,Huilai Zhang,Laura Maria Fogliatto,Clara Maluquer Artigal,Muhit Özcan,Eduardo Patricio Yanez Ruiz,Won Seog Kim,Dmitry Kirtbaya,Iryna Kriachok,Felipe Maciel,Hongwei Xue,Krimo Bouabdallah,Charles Phelps,Shalini Chaturvedi,Anke Weispfenning,Peter N. Morcos,Fatuma Catherine Atieno Odongo,Viktoriya Buvaylo,Barrett H Childs,Martin Dreyling,Matthew J. Matasar,Paola Ghione
Research Article July 26 2024
Alliance A061202: Ixazomib, pomalidomide and dexamethasone for lenalidomide-refractory multiple myeloma in first relapse
Research Article July 26 2024
Hodgkin Lymphoma Involving the Extra-Axial CNS: An AHOD1331, PHL-C1 and PHL-C2 Report From the COG and EuroNet-PHL
Research Article July 26 2024
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma
Maria Luisa Palacios-Berraquero,Paula Rodriguez-Marquez,Maria Erendira Calleja-Cervantes,Nerea Berastegui,Aintzane Zabaleta,Leire Burgos,Diego Alignani,Patxi San Martín-Úriz,Amaia Vilas-Zornoza,Saray Rodriguez-Diaz,Susana I Inoges,Ascensión López-Diaz-de-Cerio,Sofia Huerga,Luis Esteban Tamariz-Amador,Jose J Rifon,Ana Alfonso-Pierola,Juan Jose Lasarte,Bruno Paiva,Mikel Hernaez,Paula Rodriguez-Otero,Jesús F. San-Miguel,Teresa Ezponda,Juan Roberto Rodriguez-Madoz,Felipe Prosper
Letter July 26 2024
Coordinated antiviral immune response in a myeloma patient with systemic adenovirus infection post BCMA CAR T cells
Mehmet Hakan Kocoglu,Tim Luetkens,Jacqueline T. Bork,John W. Baddley,Destiny Omili,Etse Gebru,Rediet Mulatu,Daniel Yamoah,Thierry Iraguha,Xiaoxuan Fan,Patricia Lesho,Mohammad Yousaf,Jillian M Baker,Kenneth A Dietze,Kim G. Hankey,Ashraf Badros,Jean A. Yared,Aaron P. Rapoport,Nancy M Hardy,Djordje Atanackovic
Review Article July 26 2024
What's in a name: defining pediatric refractory ITP
Taizo A Nakano,Amanda B Grimes,Robert J Klaassen,Michele P Lambert,Cindy E. Neunert,Jennifer A Rothman,Kristin A Shimano,Christina Amend,Megan Askew,Sherif M Badawy,Jillian M Baker,Vicky Breakey,Shelley E Crary,Monica Davini,Stephanie Fritch Lilla,Megan Gilbert,Taru Hays,Kerry Hege,Kirsty Hillier,Amanda Jacobson-Kelly,Shipra Kaicker,Taylor Olmsted Kim,Manpreet Kochhar,Thierry M Leblanc,Marie Martinelli,Mara Nunez,Allison Sarah Remiker,Corinna L. Schultz,Ruchika Sharma,Rachael F. Grace
Research Article July 24 2024
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation
Research Article July 23 2024
Optimizing the Post-CAR T Monitoring Period for Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel
Letter July 23 2024
Molecular and Clinical Characterization of ETNK1-mutated Myeloid Neoplasms: The Mayo Clinic Experience
Research Article July 23 2024
Effect of Rabbit ATG PK on Outcomes after TCR-αβ/CD19-depleted Pediatric Haploidentical HCT for Hematologic Malignancy
Christopher C Dvorak,Janel R. Long-Boyle,Lucia Holbrook-Brown,Hisham Abdel-Azim,Alice Bertaina,Anant Vatsayan,Julie-An Talano,Nancy J. Bunin,Eric J Anderson,Allyson Flower,Nahal R Lalefar,Christine S Higham,Neena Kapoor,Orly Klein,Maryanne C Odinakachukwu,Soohee Cho,David A Jacobsohn,Willem Collier,Michael A Pulsipher
Research Article July 23 2024
T-cell dysfunction in CLL is mediated through expression of SIGLEC-10 ligands CD24 and CD52 on CLL cells
Research Article July 23 2024
Clinical Outcomes After Idecabtagene Vicleucel in Older Multiple Myeloma Patients: A Multicenter Real-world Experience
Research Article July 19 2024
CD70 identifies alloreactive T cells and represents a potential target for prevention and treatment of acute GvHD
Research Article July 19 2024
Outcomes of r/r B-cell NHL patients with limited (<5 Sites) pre-CART Disease Bridged With or Without Radiotherapy
Omran Saifi,William G Breen,Scott C. Lester,William G Rule,Bradley Stish,Allison C. Rosenthal,Javier Munoz,Yi Lin,Radhika Bansal,Matthew A Hathcock,Patrick B. Johnston,Stephen M Ansell,Jonas Paludo,Arushi Khurana,Jose Caetano Villasboas,Yucai Wang,Madiha Iqbal,Muhamad Alhaj Moustafa,Hemant S. Murthy,Ernesto Ayala,Mohamed A Kharfan-Dabaja,Bradford S. Hoppe,Jennifer L Peterson
Research Article July 19 2024
Cumulative Donor-Specific Antibody Threshold Predicts Platelet Transfusion Response in HLA-Alloimmunized Patients.
Research Article July 18 2024
Impact of Hydroxyurea on follicle density in patients with sickle cell disease
Research Article July 18 2024
A.R.R.O.W.2: Once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma
Research Article July 18 2024
Blood biodistribution and vector shedding of valoctocogene roxaparvovec in people with severe hemophilia A
Research Article July 15 2024
A brain organoid/ALL co-culture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALL
Philip Gebing,Stefanos Loizou,Sebastian Hänsch,Julian Schliehe-Diecks,Lea Spory,Pawel Stachura,Vera H Jepsen,Melina Vogt,Aleksandra A. Pandyra,Herui Wang,Zhengping Zhuang,Johannes Zimmermann,Martin Schrappe,Gunnar Cario,Ameera Alsadeq,Denis M. Schewe,Arndt Borkhardt,Lennart Lenk,Ute Fischer,Sanil Bhatia
Research Article July 15 2024
Unrelated donor transplantation with post-transplant cyclophosphamide versus ATG for myelodysplastic neoplasms
Yves Chalandon,Diderik-Jan Eikema,Ivan Sergeevich Moiseev,Fabio Ciceri,Linda Koster,Jan Vydra,Jakob R Passweg,Montserrat Rovira,Tulay Ozcelik,Tobias Gedde-Dahl,Nicolaus Kröger,Victoria Potter,Ibrahim Yakoub-Agha,Alessandro Rambaldi,Maija Itälä-Remes,Alina D Tanase,Francesco Onida,Carmelo Gurnari,Christof Scheid,Joanna Drozd-Sokolowska,Kavita Raj,Donal P McLornan,Marie Robin
Research Article July 12 2024
Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression
Review Article July 11 2024
Roctavian Gene Therapy for Hemophilia A
Letter July 11 2024
In Utero Hematopoietic Stem Cell Transplantation for Fanconi Anemia
Research Article July 11 2024
Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarnib for Relapsed/Refractory Peripheral T Cell Lymphoma
Thomas E. Witzig,Lubomir Sokol,Won Seog Kim,Fátima de la Cruz,Alejandro Martin Martin Garcia-Sancho,Ranjana H Advani,Josep Maria Roncero Vidal,Raquel De Oña,Ana Marin-Niebla,Antonia Rodriguez Izquierdo,Maria José Terol, MD,Eva Domingo-Domenech,Andrew Saunders,Nawal Bendris,Julie Mackey,Mollie Leoni,Francine M Foss
Research Article July 11 2024
Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity in Clinical Trials of Diffuse Large B-Cell Lymphoma
Research Article July 11 2024
COVID-19 mRNA Vaccination Responses in Individuals With Sickle Cell Disease: ASH RC Sickle Cell Research Network Study
Alan R. Anderson,John J Strouse,Deepa Manwani,Amanda M. Brandow,Elliott P. Vichinsky,Andrew Campbell,Patrick J Leavey,Alecia Nero,Ibrahim F Ibrahim,Joshua J Field,Amanda Baer,Haideliza Soto-Calderon,Lauren Vincent,Yan Zhao,Jefferson J.S. Santos,Scott E Hensley,Nicole Mortier,Sophie Lanzkron,Donna S. Neuberg,Charles S. Abrams
Research Article July 10 2024
Permissible HLA mismatches in 9/10 unrelated donor pediatric stem cell transplants using HLA-EMMA, an EBMT IEWP Study
Research Article July 10 2024
Phase II study of a longitudinal rehabilitation program for allogeneic blood and marrow transplantation patients
Research Article July 10 2024
Associations between acute and chronic graft-versus-host disease
Masaharu Tamaki,Yu Akahoshi,Yoshihiro Inamoto,Kaoru Morita,Naoyuki Uchida,Noriko Doki,Masatsugu Tanaka,Tetsuya Nishida,Hiroyuki Ohigashi,Hirohisa Nakamae,Makoto Onizuka,Yuta Katayama,Ken-ichi Matsuoka,Masashi Sawa,Fumihiko Ishimaru,Yoshinobu Kanda,Takahiro Fukuda,Yoshiko Atsuta,Seitaro Terakura,Junya Kanda
Research Article July 10 2024
CD19-directed CART Therapy for T cell/Histiocyte Rich Large B-cell Lymphoma
Research Article July 5 2024
Nilotinib vs. Dasatinib in Achieving MR4.5 for de novo Chronic Myeloid Leukemia: the Randomized JALSG CML212 Study
Itaru Matsumura,Shigeki Ohtake,Yoshiko Atsuta,Mio Kurata,Yosuke Minami,Naoto Takahashi,Chiaki Nakaseko,Noriyoshi Iriyama,Katsumichi Fujimaki,Kazuhiko Kakihana,Yoji Ogasawara,Takaaki Ono,Masaya Okada,Tetsuzo Tauchi,Toshihiro Miyamoto,Kazunori Ohnishi,Emiko Sakaida,Shin Fujisawa,Yukio Kobayashi,Norio Asou,Tomoki Naoe,Hitoshi Kiyoi,Yasushi Miyazaki
Research Article July 5 2024
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2 & PRN473 reduces venous thrombosis formation in mice.
Christopher W Smith,Joana Campos,Helena C Brown,Natalie J Jooss,Vanesa-Sindi Ivanova,Maan Harbi,Lourdes Garcia Quintanilla,Sian Jossi,Marisol Perez-Toledo,Kieran Rookes,Alexander Brill,Lindsay N Theodore,Tim Owens,Jacob J. La Stant,Matthew C Foulke,Shin Mukai,Michelle Francesco,Michael J Storek,Alexandra Hicks,Claire Langrish,Philip A Nunn,Adam F Cunningham,Abhishek Chauhan,Mark R Thomas,Steve P Watson,Phillip Lindsay Ross Nicolson
